Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Adalimumab was first approved in the U.S. for the treatment of aforementioned medical conditions. Currently, this is marketed in more than 60 countries. However, owing to the biologic nature of the drug, it results in high cost and low accessibility in emerging economies such as LATAM and Asia Pacific. On the other hand, with the probable entry of the adalimumab biosimilars post the patent expiry the low costs up to less than 25% to 35% of the originator drugs will boost the uptake and prescription of adalimumab for the treatment of above mentioned medical conditions.
This report elaborates on the current development of the LATAM Adalimumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Boehringer Ingelheim GmbH
Novartis AG
By Type:
Oral Type
Injection Type
By Application:
Others
Crohn’s Disease
Ulcerative Colitis
Psoriasis
Rheumatoid Arthritis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China LATAM Adalimumab Market Overview 2018-2029
-
1.1 China LATAM Adalimumab Industry Development Overview
-
1.2 China LATAM Adalimumab Industry Development History
-
1.3 China LATAM Adalimumab Industry Market Size (2018-2029)
-
1.4 China LATAM Adalimumab Market Analysis by Type from Production Side
-
1.4.1 China LATAM Adalimumab Production Volume, Production Value and Growth Rate of Oral Type (2018-2029)
-
1.4.2 China LATAM Adalimumab Production Volume, Production Value and Growth Rate of Injection Type (2018-2029)
-
1.5 China LATAM Adalimumab Market Analysis by Application from Consumption End
-
1.5.1 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Crohn’s Disease (2018-2029)
-
1.5.3 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)
-
1.5.4 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Psoriasis (2018-2029)
-
1.5.5 China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthritis (2018-2029)
-
1.6 China LATAM Adalimumab Market Analysis by Region
-
1.6.1 North China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.3 South China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.4 East China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
Chapter 2 China LATAM Adalimumab Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on LATAM Adalimumab Market Status and Competition at home and abroad in 2023
-
2.2.2 China LATAM Adalimumab Market Status and Competition Analysis in 2023
-
2.2.3 China LATAM Adalimumab Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China LATAM Adalimumab Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on LATAM Adalimumab Industry Development
Chapter 3 LATAM AdalimumabIndustry Chain Analysis
-
3.1 LATAM Adalimumab Industry Chain
-
3.2 LATAM Adalimumab Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the LATAM Adalimumab Market
-
3.3 LATAM Adalimumab Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the LATAM Adalimumab Market
Chapter 4 China LATAM Adalimumab Market, by Type
-
4.1 China LATAM Adalimumab Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China LATAM Adalimumab Total Production Volume and Growth Rate from Production Side
-
4.5 China LATAM Adalimumab Production Volume and Growth Rate, by Type
-
4.5.1 China LATAM Adalimumab Production Volume and Growth Rate of Oral Type
-
4.5.2 China LATAM Adalimumab Production Volume and Growth Rate of Injection Type
Chapter 5 China LATAM Adalimumab Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China LATAM Adalimumab Total Market Size and Growth Rate from Consumption End
-
5.5 China LATAM Adalimumab Market Size and Growth Rate, by Application
-
5.5.1 China LATAM Adalimumab Market Size and Growth Rate of Others
-
5.5.2 China LATAM Adalimumab Market Size and Growth Rate of Crohn’s Disease
-
5.5.3 China LATAM Adalimumab Market Size and Growth Rate of Ulcerative Colitis
-
5.5.4 China LATAM Adalimumab Market Size and Growth Rate of Psoriasis
-
5.5.5 China LATAM Adalimumab Market Size and Growth Rate of Rheumatoid Arthritis
Chapter 6 China LATAM Adalimumab Market, by Region
-
6.1 China LATAM Adalimumab Production Volume and Production Value, by Region
-
6.2 China LATAM Adalimumab Sales Volume and Sales Value, by Region
Chapter 7 North China LATAM Adalimumab Market Analysis
-
7.1 North China LATAM Adalimumab Market, by Type
-
7.2 North China LATAM Adalimumab Market, by Application
Chapter 8 Central China LATAM Adalimumab Market Analysis
-
8.1 Central China LATAM Adalimumab Market, by Type
-
8.2 Central China LATAM Adalimumab Market, by Application
Chapter 9 South China LATAM Adalimumab Market Analysis
-
9.1 South China LATAM Adalimumab Market, by Type
-
9.2 South China LATAM Adalimumab Market, by Application
Chapter 10 East China LATAM Adalimumab Market Analysis
-
10.1 East China LATAM Adalimumab Market, by Type
-
10.2 East China LATAM Adalimumab Market, by Application
Chapter 11 Northeast China LATAM Adalimumab Market Analysis
-
11.1 Northeast China LATAM Adalimumab Market, by Type
-
11.2 Northeast China LATAM Adalimumab Market, by Application
Chapter 12 Southwest China LATAM Adalimumab Market Analysis
-
12.1 Southwest China LATAM Adalimumab Market, by Type
-
12.2 Southwest China LATAM Adalimumab Market, by Application
Chapter 13 Northwest China LATAM Adalimumab Market Analysis
-
13.1 Northwest China LATAM Adalimumab Market, by Type
-
13.2 Northwest China LATAM Adalimumab Market, by Application
Chapter 14 Company Profiles
-
14.1 Boehringer Ingelheim GmbH
-
14.1.1 Boehringer Ingelheim GmbH Company Profile
-
14.1.2 Boehringer Ingelheim GmbH LATAM Adalimumab Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Profile
-
14.2.2 Novartis AG LATAM Adalimumab Market Performance
-
14.2.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 LATAM Adalimumab Industry Research Conclusions
-
15.2 LATAM Adalimumab Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China LATAM Adalimumab Industry Market Size (2018-2029)
-
Figure China LATAM Adalimumab Production Volume, Production Value and Growth Rate of Oral Type (2018-2029)
-
Figure China LATAM Adalimumab Production Volume, Production Value and Growth Rate of Injection Type (2018-2029)
-
Figure China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Crohn’s Disease (2018-2029)
-
Figure China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)
-
Figure China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Psoriasis (2018-2029)
-
Figure China LATAM Adalimumab Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthritis (2018-2029)
-
Figure North China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure Central China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure South China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure East China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure Northeast China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure Southwest China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure Northwest China LATAM Adalimumab Market Size and Growth Rate from 2018-2029
-
Figure LATAM Adalimumab Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China LATAM Adalimumab Market Share by Type in 2018
-
Figure China LATAM Adalimumab Market Share by Type in 2023
-
Figure China LATAM Adalimumab Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China LATAM Adalimumab Production Volume and Growth Rate of Oral Type (2018-2023)
-
Figure China LATAM Adalimumab Production Volume and Growth Rate of Injection Type (2018-2023)
-
Figure China LATAM Adalimumab Market Share by Application in 2018
-
Figure China LATAM Adalimumab Market Share by Application in 2023
-
Figure China LATAM Adalimumab Total Market Size and Growth Rate from Consumption End
-
Figure China LATAM Adalimumab Market Size and Growth Rate of Others (2018-2023)
-
Figure China LATAM Adalimumab Market Size and Growth Rate of Crohn’s Disease (2018-2023)
-
Figure China LATAM Adalimumab Market Size and Growth Rate of Ulcerative Colitis (2018-2023)
-
Figure China LATAM Adalimumab Market Size and Growth Rate of Psoriasis (2018-2023)
-
Figure China LATAM Adalimumab Market Size and Growth Rate of Rheumatoid Arthritis (2018-2023)
-
Table China LATAM Adalimumab Production Volume by Region (2018-2023)
-
Table China LATAM Adalimumab Production Volume Share by Region (2018-2023)
-
Figure China LATAM Adalimumab Production Volume Share by Region (2018-2023)
-
Table China LATAM Adalimumab Production Value by Region (2018-2023)
-
Table China LATAM Adalimumab Production Value Share by Region (2018-2023)
-
Figure China LATAM Adalimumab Production Value Share by Region (2018-2023)
-
Table China LATAM Adalimumab Sales Volume by Region (2018-2023)
-
Table China LATAM Adalimumab Sales Volume Share by Region (2018-2023)
-
Figure China LATAM Adalimumab Sales Volume Share by Region (2018-2023)
-
Table China LATAM Adalimumab Sales Value by Region (2018-2023)
-
Table China LATAM Adalimumab Sales Value Share by Region (2018-2023)
-
Figure China LATAM Adalimumab Sales Value Share by Region (2018-2023)
-
Table North China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table North China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure North China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table North China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table North China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure North China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table Central China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table Central China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure Central China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table Central China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table Central China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure Central China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table South China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table South China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure South China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table South China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table South China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure South China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table East China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table East China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure East China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table East China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table East China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure East China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table Northeast China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table Northeast China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure Northeast China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table Northeast China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table Northeast China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure Northeast China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table Southwest China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table Southwest China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure Southwest China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table Southwest China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table Southwest China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure Southwest China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table Northwest China LATAM Adalimumab Production Volume by Type (2018-2023)
-
Table Northwest China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Figure Northwest China LATAM Adalimumab Production Volume Share by Type (2018-2023)
-
Table Northwest China LATAM Adalimumab Sales Volume by Application (2018-2023)
-
Table Northwest China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Figure Northwest China LATAM Adalimumab Sales Volume Share by Application (2018-2023)
-
Table Boehringer Ingelheim GmbH Company Profile
-
Table Boehringer Ingelheim GmbH LATAM Adalimumab Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG LATAM Adalimumab Revenue, Price and Gross (2018-2023)
-
